If there has been a silver lining behind the otherwise menacing COVID-19 pandemic clouds for any sector of B.C.’s economy, it has been life sciences.

Vancouver’s SaNOtize Research and Development Corp. had already been in Phase 2 clinical trials for a spray that uses nitric oxide to treat chronic sinusitis and had an anti-viral formulation in the pipeline. So it was well positioned for a swift pivot to test the spray as a nasal sanitizer for preventing COVID-19 infections.

Read more here.